|
Report No. : |
337973 |
|
Report Date : |
26.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
HETLABS MÉXICO, S.A. DE C.V. |
|
|
|
|
Registered Office : |
Av Ciudad Universitaria No 286 Int 202, Ciudad de México, Distrito Federal 01900 |
|
|
|
|
Country : |
Mexico |
|
|
|
|
Date of Incorporation : |
2012 |
|
|
|
|
Legal Form : |
Sociedad Anónima De Capital Variable |
|
|
|
|
Line of Business : |
Import and Wholesale of Drugs. |
|
|
|
|
No. of Employees : |
22 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Slow but correct |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Mexico |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
MEXICO - ECONOMIC OVERVIEW
Mexico's $1.3 trillion economy has become increasingly
oriented toward manufacturing in the 21 years since the North American Free
Trade Agreement (NAFTA) entered into force. Per capita income is roughly
one-third that of the US; income distribution remains highly unequal. Mexico
has become the United States' second-largest export market and third-largest
source of imports. In 2014, two-way trade in goods and services exceeded $550
billion. Mexico has free trade agreements with 46 countries, putting more than
90% of trade under free trade agreements. In 2012, Mexico formally joined the
Trans-Pacific Partnership negotiations and formed the Pacific Alliance with
Peru, Colombia and Chile. Mexico's current government, led by President Enrique
PENA NIETO, emphasized economic reforms during its first two years in office,
passing and implementing sweeping education, energy, financial, fiscal and
telecommunications reform legislation, among others, with the long-term aim to
improve competitiveness and economic growth across the Mexican economy.
Although the economy is expected to experience stronger growth in 2015 as a
result of increased investment and stronger demand for Mexican exports, growth
is predicted to remain below potential for reasons of inefficiencies, with a
large portion of the economy and workforce in the informal sector, and
corruption. Over the medium-term, the economy is vulnerable to global economic
pressures, such as lower external demand, rising interest rates, and low oil
prices - approximately 30% of government revenue comes from the state-owned oil
company, PEMEX. The increasing integration of supply chains, development of the
energy sector, and government-to-government focus on trade facilitation will
continue to make the North American region increasingly competitive and
contribute to Mexican economic development and strength.
|
Source
: CIA |
STATUTORY
INFORMATION
|
|
|
Legal Name: |
HETLABS MÉXICO, S.A. DE C.V. |
|
Trade Name: |
Heterodrugs Mexico |
|
RFC: |
HME1105034S3 |
|
Date Created: |
2012 |
|
Date Incorporated: |
2012 |
|
Legal Address: |
Av Ciudad Universitaria No 286 Int 202 |
|
Operative Address: |
Av Ciudad Universitaria No 286 Int 202 |
|
Telephone: |
55 5616 3196 |
|
Fax: |
55 5616 3196 |
|
Legal Form: |
Sociedad Anónima de Capital Variable |
|
Email: |
|
|
Registered in: |
Mexico |
|
Website: |
|
|
Contact: |
Adrián Ruiz, General Director |
|
Staff: |
22 |
|
Activity: |
Pharmaceutical Industry |
|
|
|
|
BANKS |
BANAMEX |
|
|
|
|
|
The company does not make its banking data public |
History
|
|
|
|
The company initiated business in Mexico in 2012. |
|
|
Indian company Hetero Drugs to open new plant in Mexico
The Indian company Hetero Drugs plans to invest $ 50 million for a new
plant in Mexico, this in order to consolidate in the domestic market as one
of the major players in the pharmaceutical industry. That was announced by
the CEO of the company, Adrian Ruiz, who said the goal is to "further
developed as one of the leading manufacturers and suppliers of active
ingredient in the region." |
PRINCIPAL
ACTIVITY
|
|
|
|
The company is dedicated to the import and wholesale of drugs. |
|
Products/Services description: |
Hetero Drug currently has 55 completed products in Mexico negotiating with
transnational corporations and more than 300 line products are in development
for the next five years. |
|
Brands: |
HETERODRUGS |
|
Sales are: |
Wholesale |
|
Clients: |
SIEGFRIED RHEIN SA DE CV |
|
Suppliers: |
Hetero Labs Ltd. |
|
Operations area: |
National and International |
|
The company imports from |
India |
|
The company exports to |
No exports |
|
The subject employs |
22 employees |
|
Payments: |
Slow but correct |
|
|
|
LOCATION
|
|
|
Headquarters : |
Av Ciudad Universitaria No 286 Int 202 |
|
Branches: |
The company does not have branches |
|
|
|
|
|
|
GROUP
STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders: |
The company is held by: Hetero Labs Limited India |
|
Management: |
Ruíz Parra Adrián Gabriel, General Manager |
|
|
|
FINANCIAL
INFORMATION
|
|
|
|
The company does not make its financial figures public. The following
information was confirmed by the company. |
|
|
|
|
Annual Sales USD 2014 |
|
|
Revenue |
40 000 000 |
|
Cash flow |
Good |
|
|
|
LEGAL
FILINGS
|
|
|
|
|
|
|
Date: 19/09/2013 |
|
|
|
SUMMARY
|
|
|
|
The company is dedicated to the import and wholesale of drugs. It has 3 years of experience in the Mexican market with a small sized
structure. The company is held by the Indian Hetero Labs Limited with
international presence and plans to expand through Latin America. There are no negative for the subject. |
|
|
|
RISK
INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
Slow but correct |
|
CASH FLOW |
Normal |
|
STATUS |
Active |
|
|
|
|
INTERVIEW |
|
|
NAME |
Jose Sandovar |
|
POSITION |
NA |
|
COMMENTS |
He confirmed president’s name, staff, address, ownership. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.71 |
|
|
1 |
Rs.105.10 |
|
Euro |
1 |
Rs.77.11 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.